Evoke Pharma Profit Margin 2012-2024 | EVOK
Current and historical gross margin, operating margin and net profit margin for Evoke Pharma (EVOK) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Evoke Pharma net profit margin as of December 31, 2024 is -52.22%.
| Evoke Pharma Annual Profit Margins |
| Evoke Pharma Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.005B |
$0.010B |
|
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
|
